Last reviewed · How we verify
Bifidobacterium infantis
At a glance
| Generic name | Bifidobacterium infantis |
|---|---|
| Also known as | B. Bifidum, B. Breve, B. Infantis, Bifidobacterias, Bifidobacterium bifidum |
| Sponsor | American Academy of Family Physicians |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Treatment of Histamine Intolerance Using Probiotic Intervention (NA)
- The Effect of a Multispecies Probiotics on Autism Symptoms in Children (NA)
- The Effect of Bifidobacterium Probiotics on Gut Microbiota Changes in Healthy Adults During Short-term Travel Along the Silk Road (PHASE2)
- Infant Microbiota and Probiotic Intake Study (NA)
- Effect of Probiotics on Quality of Life, Activities of Daily Living and Anxiety in Post Stroke Patients (NA)
- Effect of Probiotic Intervention on Travel-Related Health Conditions During Short-Term Overseas Travel (PHASE2)
- Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE) (NA)
- 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |